MAPT and Parkinson disease: For example, post-mortem AD and PD brains show that the levels of several other tyrosine kinases are elevated there and also the knockdown of these tyrosine kinases was shown to reduce aggregation of neurotoxic proteins, including α-synuclein, β-amyloid and tau [133].